Literature DB >> 3610570

A new family of vertebrate viruses: Toroviridae.

M C Horzinek, T H Flewett, L J Saif, W J Spaan, M Weiss, G N Woode.   

Abstract

The proposed family Toroviridae is characterized by eveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. The capsid may bend into an open torus, conferring a biconcave disk or kidney-shaped morphology to the virion (largest diameter 120-140 nm) or the capsid may be straight, resulting in a rod-shaped particle (35 X 170 nm). Morphogenesis is by budding of preformed nucleocapsids through membranes mainly of the Golgi system and of the rough endoplasmic reticulum. Berne virus, which is proposed as the family prototype, contains a single strand of infectious positive-sense RNA, Mr about 6.5 X 10(6), which is polyadenylated. The RNA is surrounded by the major nucleocapsid phosphoprotein (Mr about 20,000) which, in turn, is enveloped by a membrane containing one major protein (Mr 22,000) and a phosphoprotein (Mr 37,000). The viral peplomers, about 20 nm long, carry determinants for neutralization and hemagglutination; they are formed by a polydisperse N-glycosylated protein (Mr 75,000-100,000). Four major subgenomic polyadenylated RNAs have been identified in infected cells, with Mrs of 3.0, 0.71, 0.46 and 0.26 X 10(6). Torovirus replication is inhibited by actinomycin D, alpha-amanitin and pre-irradiation of the host cell with UV light. All toroviruses identified so far cause enteric infections and are probably transmitted by the fecal-oral route. Serologic relationships between equine, bovine and human toroviruses have been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610570     DOI: 10.1159/000149710

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  20 in total

1.  cDNA probes for the diagnosis of bovine torovirus (Breda virus) infection.

Authors:  M Koopmans; E J Snijder; M C Horzinek
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  VI, 1. Epidemiology of toroviruses.

Authors:  Martin Petric
Journal:  Perspect Med Virol       Date:  2004-09-14

3.  A 3'-coterminal nested set of independently transcribed mRNAs is generated during Berne virus replication.

Authors:  E J Snijder; M C Horzinek; W J Spaan
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  Bovine torovirus: sequencing of the structural genes and expression of the nucleocapsid protein of Breda virus.

Authors:  L M Duckmanton; R Tellier; P Liu; M Petric
Journal:  Virus Res       Date:  1998-11       Impact factor: 3.303

5.  Enzyme-linked immunosorbent assay reactivity of torovirus-like particles in fecal specimens from humans with diarrhea.

Authors:  M Koopmans; M Petric; R I Glass; S S Monroe
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

6.  The role of torovirus in nosocomial viral gastroenteritis at a large tertiary pediatric centre.

Authors:  Jb Gubbay; A Al-Rezqi; M Hawkes; L Williams; Se Richardson; A Matlow
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  The carboxyl-terminal part of the putative Berne virus polymerase is expressed by ribosomal frameshifting and contains sequence motifs which indicate that toro- and coronaviruses are evolutionarily related.

Authors:  E J Snijder; J A den Boon; P J Bredenbeek; M C Horzinek; R Rijnbrand; W J Spaan
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

8.  Classical and molecular techniques for the diagnosis of viral gastroenteritis.

Authors:  U Desselberger
Journal:  Clin Diagn Virol       Date:  1996-05

9.  Lineage specific antigenic differences in porcine torovirus hemagglutinin-esterase (PToV-HE) protein.

Authors:  Jaime Pignatelli; Julio Alonso-Padilla; Dolores Rodríguez
Journal:  Vet Res       Date:  2013-12-23       Impact factor: 3.683

Review 10.  Toroviruses of animals and humans: a review.

Authors:  M Koopmans; M C Horzinek
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.